Filing
Spy
Filing
Spy
Home
About
VRTX — Vertex Pharmaceuticals Inc - FilingSpy
VRTX
Vertex Pharmaceuticals Inc
Biopharmaceutical company
CUSIP: 92532F100
Healthcare
US
2 holders
Ownership
Activity
Fundamentals
2015 Q1
29 of 31 quarters
Total Value
$270.74M
Total Shares
2.30M
Net Share Change
+1.53M
Activity
2 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$208.82M
1.77M
0.8%
ADD
+1.01M
(+131.6%)
Viking Global Investors
$208.82M
1.77M shares
ADD
+1.01M
(+131.6%)
Maverick Capital
$61.92M
524.9K
1.0%
NEW
Maverick Capital
$61.92M
524.9K shares
NEW